Update shared on 10 Nov 2025
Fair value Decreased 0.035%Narrative Update: Medacta Group Price Target Adjustment
Analysts have slightly lowered their fair value estimate for Medacta Group from CHF164.46 to CHF164.40, citing minor model updates that reflect changes in discount rate assumptions.
What's in the News
- Medacta Group SA confirmed its earnings guidance for 2025, targeting revenue growth of 16% to 18% in constant currency, subject to unforeseen events (Company Guidance).
Valuation Changes
- Fair Value Estimate has decreased marginally from CHF164.46 to CHF164.40.
- Discount Rate has increased slightly from 4.60% to 4.72%.
- Revenue Growth projections remain effectively unchanged at approximately 12.37%.
- Net Profit Margin forecast is stable, holding at around 13.38%.
- Future P/E Ratio has edged down marginally from 33.12x to 33.07x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.